Vimarsana
Biggest News Aggregation in the World

Tang Tjun Yip News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tang Tjun Yip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tang Tjun Yip Today - Breaking & Trending Today

18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR Presented as Late Breaking Trial at VIVA - Vimarsana News

18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR Presented as Late Breaking Trial at VIVA

Published: October 11, 2021

GENEVA, Oct. 11, 2021 /PRNewswire/ -- 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21. The objective of this clinical

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomSwitzerland GeneralRichard KenyonTang Tjun YipKostenloser WertpapierhandelMa Med AllianceCell Adherent TechnologyHospital Department Of Vascular SurgeryLate Breaking Clinical TrialCritical Limb IschemiaLate Breaking TrialTarget Lesion RevascularizationAmputation Free SurvivalSingapore General HospitalAssociate Professors Chong Tze TecSenior ConsultantPeripheral Artery DiseaseMedalliance ChairmanSelution Sirolimus Coated Balloon
18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at VIVA - Vimarsana News

18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at VIVA

Published: October 11, 2021

GENEVA, Oct. 11, 2021 /PRNewswire/ - 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial - Report on The Eastern Herald

Source: easternherald.com
Related Topics:
United StatesUnited KingdomSwitzerland GeneralRichard KenyonTang Tjun YipMa Med AllianceCell Adherent TechnologyHospital Department Of Vascular SurgeryLate Breaking Clinical TrialCritical Limb IschemiaTarget Lesion RevascularizationAmputation Free SurvivalSingapore General HospitalAssociate ProfessorsChong Tze TecSenior ConsultantPeripheral Artery DiseaseMedalliance ChairmanSelution Sirolimus Coated Balloon
18-Month Below-the-Knee data with MedAlliance's SELUTION SLRtrade; presented as Late Breaking Trial at VIVA - Vimarsana News

18-Month Below-the-Knee data with MedAlliance's SELUTION SLRtrade; presented as Late Breaking Trial at VIVA

Published: October 11, 2021

18-month results from the PRESTIGE Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21.

Source: singaporestar.com
Related Topics:
Tang Tjun YipCell Adherent TechnologyHospital Department Of Vascular SurgeryLate Breaking Clinical TrialCritical Limb IschemiaTarget Lesion RevascularizationAmputation Free SurvivalSingapore General HospitalAssociate Professors Chong Tze TecHeadsenior ConsultantSenior ConsultantPeripheral Artery DiseaseMedalliance ChairmanSwitzerland NewsArtery DiseaseBeen With
18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at VIVA - Vimarsana News

18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at VIVA

Published: October 8, 2021

/PRNewswire/ -- 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21. The objective...

Source: prnewswire.com
Related Topics:
Richard KenyonTang Tjun YipMa Med AllianceCell Adherent TechnologyHospital Department Of Vascular SurgerySingapore General HospitalAssociate ProfessorsChong Tze TecSenior ConsultantPeripheral Artery DiseaseMedalliance ChairmanSelution Sirolimus Coated Balloon